Hu, Y., Tan, Q., Zhang, J., Zhang, M., Wu, W., Wei, G., Tan, B., Cui, J., Wu, Y., Li, D., Du, B., Liu, M., Huang, H. (2025). Long term remission and survival in patients with relapsed or refractory non-Hodgkin lymphoma after treatment of brl-201, a CRISPR-based non-viral PD-1 locus specifically integrated anti-CD19 CAR-T cells: 4-year follow-up of a first-in-human phase I study. Blood. https://doi.org/10.1182/blood-2025-5930